How to Change Your Stock Portfolio During a Bear Market
The standard definition of a bear market is that one…
Sell
43
FCX Quote, Financials, Valuation and Earnings
Last price:
$38.02
Seasonality move
:
1.33%
Day range:
$36.99 - $38.12
52-week range:
$27.66 - $55.24
Dividend yield:
1.58%
P/E ratio:
31.42x
P/S ratio:
2.21x
P/B ratio:
3.09x
Volume:
13.5M
Avg. volume:
18.2M
1-year change:
-26.94%
Market cap:
$54.6B
Revenue:
$25.5B
EPS (TTM):
$1.21
Analysts' Opinion
-
Consensus RatingFreeport-McMoRan has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $44.07, Freeport-McMoRan has an estimated upside of 15.91% from its current price of $38.02.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $26.00 representing 100% downside risk from its current price of $38.02.
Fair Value
-
According to the consensus of 14 analysts, Freeport-McMoRan has 15.91% upside to fair value with a price target of $44.07 per share.
FCX vs. S&P 500
-
Over the past 5 trading days, Freeport-McMoRan has underperformed the S&P 500 by -4.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Freeport-McMoRan does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Freeport-McMoRan revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Freeport-McMoRan reported revenues of $5.7B.
Earnings Growth
-
Freeport-McMoRan earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Freeport-McMoRan reported earnings per share of $0.24.
Enterprise value:
71.1B
EV / Invested capital:
--
Price / LTM sales:
2.21x
EV / EBIT:
10.43x
EV / Revenue:
2.86x
PEG ratio (5yr expected):
4.44x
EV / Free cash flow:
44.58x
Price / Operating cash flow:
34.41x
Enterprise value / EBITDA:
7.96x
Gross Profit (TTM):
$7.3B
Return On Assets:
3.21%
Net Income Margin (TTM):
7.11%
Return On Equity:
6.15%
Return On Invested Capital:
4.64%
Operating Margin:
22.75%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $21.6B | $23.8B | $24.9B | $6.3B | $5.7B | |
| Gross Profit | $6.6B | $7.2B | $7.3B | $1.9B | $1.5B | |
| Operating Income | $5.8B | $6.3B | $6.5B | $1.6B | $1.3B | |
| EBITDA | $8.1B | $8.9B | $8.9B | $2.4B | $1.8B | |
| Diluted EPS | $1.79 | $1.13 | $1.21 | $0.32 | $0.24 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $10.9B | $15.3B | $14.7B | $14.8B | $13.8B | |
| Total Assets | $43.6B | $48.8B | $50.9B | $54.2B | $56B | |
| Current Liabilities | $4.6B | $6.5B | $5.3B | $6.3B | $5.9B | |
| Total Liabilities | $24.1B | $24.8B | $25.3B | $26.1B | $26.8B | |
| Total Equity | $19.6B | $24B | $25.6B | $28.1B | $29.2B | |
| Total Debt | $9.8B | $9.6B | $9.6B | $9.4B | $9.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.5B | $6.1B | $6.3B | $1.9B | $1.1B | |
| Cash From Investing | -$3.9B | -$5.1B | -$4.9B | -$1.3B | -$1.2B | |
| Cash From Financing | -$2.1B | -$1.8B | -$2.8B | -$342M | $155M | |
| Free Cash Flow | $631M | $1.2B | $1.6B | $642M | -$114M | |
FCX
Sector
Market Cap
$54.6B
$18.1M
Price % of 52-Week High
68.83%
63.06%
Dividend Yield
1.58%
0%
Shareholder Yield
--
1.05%
1-Year Price Total Return
-26.94%
-16.67%
Beta (5-Year)
1.647
0.776
Dividend yield:
1.58%
Annualized payout:
$0.60
Payout ratio:
48.93%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$38.31
200-day SMA
Sell
Level
$41.10
Bollinger Bands (100)
Buy
Level
34.97 - 39.95
Chaikin Money Flow
Buy
Level
730.3M
20-day SMA
Buy
Level
$37.17
Relative Strength Index (RSI14)
Buy
Level
54.44
ADX Line
Buy
Level
14.96
Williams %R
Neutral
Level
-41.8567
50-day SMA
Buy
Level
$36.81
MACD (12, 26)
Buy
Level
0.78
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
1.6B
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3245)
Sell
CA Score
(Annual)
Level (-0.5023)
Buy
Beneish M-Score
(Annual)
Level (-3.2747)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.0244)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2024, making it the one of the world’s largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. It had about 25 years of copper reserves at the end of December 2024. We expect it to sell similar amounts of copper midcycle in 2029, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.
Stock Forecast FAQ
In the current month, FCX has received 8 Buy ratings 6 Hold ratings, and 0 Sell ratings. The FCX average analyst price target in the past 3 months is $44.07.
-
Where Will Freeport-McMoRan Stock Be In 1 Year?
According to analysts, the consensus estimate is that Freeport-McMoRan share price will rise to $44.07 per share over the next 12 months.
-
What Do Analysts Say About Freeport-McMoRan?
Analysts are divided on their view about Freeport-McMoRan share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Freeport-McMoRan is a Sell and believe this share price will drop from its current level to $26.00.
-
What Is Freeport-McMoRan's Price Target?
The price target for Freeport-McMoRan over the next 1-year time period is forecast to be $44.07 according to 14 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is FCX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Freeport-McMoRan is a Buy. 8 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of FCX?
You can purchase shares of Freeport-McMoRan via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Freeport-McMoRan shares.
-
What Is The Freeport-McMoRan Share Price Today?
Freeport-McMoRan was last trading at $38.02 per share. This represents the most recent stock quote for Freeport-McMoRan. Yesterday, Freeport-McMoRan closed at $38.02 per share.
-
How To Buy Freeport-McMoRan Stock Online?
In order to purchase Freeport-McMoRan stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Newegg Commerce Up So Much?
Consumer electronics eCommerce store Newegg (NASDAQ:NEGG) has staged a dramatic…
Is Unity Software a Buy Now?
Unity Software (NYSE:U) is the company behind the popular Unity…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 17
Semler Scientific [SMLR] is up 28.56% over the past day.
Sell
25
GLOB alert for May 17
Globant SA [GLOB] is down 23.54% over the past day.
Buy
94
HIMS alert for May 17
Hims & Hers Health [HIMS] is up 10.38% over the past day.
